Cargando…

Stress as a Potential Regulatory Factor in the Outcome of Pharmacotherapy

Detalles Bibliográficos
Autores principales:	Konstandi, Maria, Johnson, Elizabeth O., Lang, Matti A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984175/ https://www.ncbi.nlm.nih.gov/pubmed/35401076 http://dx.doi.org/10.3389/fnins.2022.737716

Ejemplares similares

Age-related modifications in CYP-dependent drug metabolism: role of stress
por: Konstandi, Maria, et al.
Publicado: (2023)

Pharmacotherapy of Pain in the Older Population: The Place of Opioids
por: Prostran, Milica, et al.
Publicado: (2016)

Sex-Specific Pharmacotherapy for Migraine: A Narrative Review
por: Gazerani, Parisa, et al.
Publicado: (2020)

Systems Biology of Immunomodulation for Post-Stroke Neuroplasticity: Multimodal Implications of Pharmacotherapy and Neurorehabilitation
por: Alam, Mohammed Aftab, et al.
Publicado: (2016)

Potential pharmacotherapy for Zinner syndrome
por: Takeshima, Teppei
Publicado: (2023)

Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice
por: Paes-Colli, Yolanda, et al.
Publicado: (2022)

Editorial: Opportunities and Challenges for Drug Discovery From Natural Products in Pharmacotherapy of Neurological Disorders
por: Jeandet, Philippe, et al.
Publicado: (2022)

The Rationale for Potential Pharmacotherapy of COVID-19
por: Saber-Ayad, Maha, et al.
Publicado: (2020)

Color Atlas of Pharmacology
por: Konstandi, Maria
Publicado: (2010)

Adjunct pharmacotherapy for psychotherapy
por: Lochtenberg, Jessica, et al.
Publicado: (2021)

Better Together? Coupling Pharmacotherapies and Cognitive Interventions With Non-invasive Brain Stimulation for the Treatment of Addictive Disorders
por: Spagnolo, Primavera A., et al.
Publicado: (2020)

Treatment of posttraumatic stress disorder: Focus on pharmacotherapy
por: Ehret, Megan
Publicado: (2019)

Regulatory Pathways of Monoamine Oxidase A during Social Stress
por: Higuchi, Yuki, et al.
Publicado: (2017)

Combining Non-Pharmacological Treatments with Pharmacotherapies for Neurological Disorders: A Unique Interface of the Brain, Drug–Device, and Intellectual Property
por: Bulaj, Grzegorz
Publicado: (2014)

Genetic Pharmacotherapy as an Early CNS Drug Development Strategy: Testing Glutaminase Inhibition for Schizophrenia Treatment in Adult Mice
por: Mingote, Susana, et al.
Publicado: (2016)

Role of PPARα and HNF4α in Stress-Mediated Alterations in Lipid Homeostasis
por: Konstandi, Maria, et al.
Publicado: (2013)

Potential self-regulatory mechanisms of yoga for psychological health
por: Gard, Tim, et al.
Publicado: (2014)

Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies
por: Kositsyn, Yuriy M., et al.
Publicado: (2023)

Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy
por: Campbell, Noll L, et al.
Publicado: (2015)

Pharmacotherapy : a pathophysiologic approach /
Publicado: (2002)

Pharmacotherapy : a pathophysiologic approach /
Publicado: (2020)

Neuroprotection in late life attention-deficit/hyperactivity disorder: A review of pharmacotherapy and phenotype across the lifespan
por: Dutta, Cintya Nirvana, et al.
Publicado: (2022)

Pharmacotherapy for Fibromyalgia
por: Smith, Howard S., et al.
Publicado: (2011)

Antiglaucoma pharmacotherapy
por: Tătaru, CP, et al.
Publicado: (2012)

Pharmacotherapies for COPD
por: Ejiofor, Stan, et al.
Publicado: (2013)

Pharmacotherapy for Retinoblastoma
por: Shahsavari, Mohsen, et al.
Publicado: (2009)

Pharmacotherapy for Obesity
por: Joo, Jong Kil, et al.
Publicado: (2014)

Pharmacotherapy for Nocturia
por: Andersson, Karl-Erik, et al.
Publicado: (2018)

Pharmacotherapy of Insomnia
por: Neubauer, David N, et al.
Publicado: (2018)

Pharmacology and Pharmacotherapy
por: Berger, Dietmar P., et al.
Publicado: (2008)

The Potential Role of Combination Pharmacotherapy to Improve Outcomes of Pediatric Obesity: A Case Report and Discussion
por: Fox, Claudia K., et al.
Publicado: (2018)

The potential role of lactulose pharmacotherapy in the treatment and prevention of diabetes
por: Chu, Natural, et al.
Publicado: (2022)

Factors Affecting Adherence to Pharmacotherapy in Parkinson's Disease
por: Aggarwal, Shivaansh, et al.
Publicado: (2021)

The Potential Circular RNAs Biomarker Panel and Regulatory Networks of Parkinson’s Disease
por: Xiao, Yousheng, et al.
Publicado: (2022)

Dynamical properties of gene regulatory networks involved in long-term potentiation
por: Nido, Gonzalo S., et al.
Publicado: (2015)

Consideration of sex as a biological variable in the translation of pharmacotherapy for stress-associated drug seeking
por: Martin, Erin L., et al.
Publicado: (2021)

Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System
por: Barkoff, Courtney M., et al.
Publicado: (2020)

Pharmacotherapy of post-traumatic stress disorder: going beyond the guidelines
por: Davidson, Jonathan
Publicado: (2016)

Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes
por: Kaul, Subuhi, et al.
Publicado: (2020)

Kidney Drug Transporters in Pharmacotherapy
por: Łapczuk-Romańska, Joanna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5ufup2m4f6dl85s923rmgk815n